BioSpace News Archive

Imara, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation to IMR-687, the company’s lead product candidate for the treatment of sickle cell disease.

GT Biopharma, Inc. announced that the results of its second Phase I-II trial for GTB-1550, an MTBDC targeting CD22 and CD19 for treatment of refractory B-cell malignancies, will be published on-line in conjunction with the 55th Annual Meeting of the American Society of Clinical Oncology in Chicago from May 31 – June 4.

ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, is participating in the JLABS @ Toronto conference, “Science 1st: Common Pathways and Mechanisms in Neurodegenerative Diseases” on May 30, 2019.

ReForm Biologics announced the appointment of Alan Herman, Ph.D. and Fred Larimore, Ph.D. to the company’s Scientific Advisory Board (SAB).

Exfoliating your skin is an important part of any dermal care routine.

EUSA Pharma announces that the Principal Investigators from two studies of QARZIBA®▼1,2 in the treatment of high-risk neuroblastoma will present new data at the 2019 American Society of Clinical Oncology Annual Meeting to be held May 31 through June 4, 2019 in Chicago, IL.

Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration to market its Aperio AT2 DX System for clinical diagnosis in the U.S.

Picosun Group, the global provider of AGILE ALD™ thin film coating solutions, continues its breakthrough into healthcare industries by supplying ALD technology to produce bioactive coatings on surgical implants at a major, leading manufacturer.

Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.

Hospital Performance Varies on Unnecessary Cesarean Sections, Early Elective Deliveries and Episiotomies